Plasma free 3-methpxy-4-hydroxyphenylglycol predicts response to fluoxetine

Huei Chen Ko, Ru Band Lu, I. Shin Shiah, Cheng Chia Hwang

研究成果: Article同行評審

18 引文 斯高帕斯(Scopus)

摘要

This study was designed to investigate the relationship between platelet serotonin (5-HT) and plasma-free 3-methoxy-4-hydronyphenylglycol (MHPG) measures in depressed outpatients obtained from the same patient with unipolar depression during the pretreatment period and subsequent response to 6 weeks of treatment with either fluoxetine or maprotiline. Compared to the nonresponder group, the fluoxetine responders showed significantly higher pretreatment levels of MHPG, but no difference in pretreatment 5-HT levels. There were no significant differences in either 5-HT or MHPG levels between maprotiline responders and nonresponders. As to posttreatment levels, there were no between-group differences in 5-HT or MHPG between responders and nonresponders to either fluoxetine or maprotiline. When the relationships between changes in 5-HT or MHPG levels and treatment response were examined, 5-HT values showed a marked decrease in both fluoxetine responders and nonresponders, but no significant changes were found in the maprotiline treatment groups. On the other hand, MHPG levels in the fluoxetine nonresponders tended to increase (borderline significance), whereas the MHPG levels for fluoxetine responders and maprotiline responders and nonresponders were unaffected from pre- to posttreatment. Pretreatment levels of plasma free MHPG appear to predict response to fluoxetine.

原文English
頁(從 - 到)774-781
頁數8
期刊Biological Psychiatry
41
發行號7
DOIs
出版狀態Published - 1997 四月 1

All Science Journal Classification (ASJC) codes

  • Biological Psychiatry

指紋 深入研究「Plasma free 3-methpxy-4-hydroxyphenylglycol predicts response to fluoxetine」主題。共同形成了獨特的指紋。

引用此